参考文献

[1]WEINER H L. Immune mechanisms and shared immune targets in neurodegenerative diseases[J]. Nat Rev Neurol,2025,21(2):67-85.

[2]RICCI C. Neurodegenerative disease:from molecular basis to therapy,2nd edition[J]. Int J Mol Sci,2025,26(5):1929.

[3]张儒奇，田明涵，王盛春.基于“脑-督脉-肾”轴探讨帕金森病的针灸治疗[J].山东中医杂志，2025,44(5):545-549.

[4]TWAROWSKI B,HERBET M. Inflammatory processes in Alzheimer’s disease-pathomechanism,diagnosis and treatment:a review[J]. Int J Mol Sci,2023,24(7):6518.

[5]KOYCHEV I,REID G,NGUYEN M,et al. Inflammatory proteins associated with Alzheimer’s disease reduced by a GLP1 receptor agonist:a post hoc analysis of the EXSCEL randomized placebo controlled trial[J]. Alzheimers Res Ther,2024,16(1):212.

[6]XU Y,LIN F,LIAO G L,et al. Ripks and neuroinflammation[J]. Mol Neurobiol,2024,61(9):6771-6787.

[7]王若楠，简中意，于兰兰，等.翻译后修饰调控神经退行性疾病相关蛋白质聚集体的构象多态性研究[J].中国科学（化学），2025,55(4):785-807.

[8]刘安婷，陆江涛，张文杰，等.血小板裂解物调控腺苷酸活化蛋白激酶抑制镉诱导的神经细胞凋亡[J].中国组织工程研究，2026,30(7):1800-1807.

[9]GORJI A. Neuroinflammation:the pathogenic mechanism of neurological disorders[J]. Int J Mol Sci,2022,23(10):5744.

[10]荆玮，SAEREETAVEEKUN N,VORATUNYAKIT N，等.神经退行性疾病与错误折叠异常聚集的蛋白质以及睡眠障碍[J].神经病学与神经康复学杂志，2024,20(2):58-66.

[11]NAVABI S M,ELIEH-ALI-KOMI D,AFSHARI D,et al.Adjunctive silymarin supplementation and its effects on disease severity,oxidative stress,and inflammation in patients with Alzheimer’s disease[J]. Nutr Neurosci,2024,27(10):1077-1087.

[12]RADBAKHSH S,ABREGO-GUANDIQUE D M,BACCHETTI T,et al. Direct hybridization and bioinformatics analysis of circulating microRNAs in patients with Alzheimer’s disease under intravenous trehalose treatment[J]. Brain Res,2025,1857:149607.

[13]FERGUSON R,GOOLD R,COUPLAND L,et al. Therapeutic validation of MMR-associated genetic modifiers in a human ex vivo model of Huntington disease[J].Am J Hum Genet,2024,111(6):1165-1183.

[14]DILEEP V,BOIX C A,MATHYS H,et al. Neuronal DNA double-strand breaks lead to genome structural variations and 3D genome disruption in neurodegeneration[J]. Cell,2023,186(20):4404-4421.e20.

[15]ZHENG Q Y,WANG X. Alzheimer’s disease:insights into pathology,molecular mechanisms,and therapy[J].Protein Cell,2025,16(2):83-120.

[16]CHEN Z H,WANG X R,DU S M,et al. A review on traditional Chinese medicine natural products and acupuncture intervention for Alzheimer’s disease based on the neuroinflammatory[J]. Chin Med,2024,19(1):35.

[17]TANNER C M,OSTREM J L. Parkinson’s disease[J].N Engl J Med,2024,391(5):442-452.

[18]DAI L J,LIU M,KE W,et al. Lysosomal dysfunction in α-synuclein pathology:molecular mechanisms and therapeutic strategies[J]. Cell Mol Life Sci ,2024 ,81(1):382.

[19]白管兵，潘波，潘娜.初治帕金森病非运动症状患者不同治疗方案疗效及脑活动改变的静息态fMRI分析[J].中国中西医结合影像学杂志，2024,22(6):676-681.

[20]MUNOZ-PINTO M F,CANDEIAS E,MELO-MARQUES I,et al. Gut-first Parkinson’s disease is encoded by gut dysbiome[J]. Mol Neurodegener,2024,19(1):78.

[21]SAADE J,MESTRE T A. Huntington’s disease:latest frontiers in therapeutics[J]. Curr Neurol Neurosci Rep,2024,24(8):255-264.

[22]NOURELDEEN M E,SHAHIN N N,AMIN H A A,et al.Parthenolide ameliorates 3-nitropropionic acid-induced Huntington’s disease-like aberrations via modulating NLRP3 inflammasome,reducing microglial activation and inducing astrocyte shifting[J]. Mol Med,2024,30(1):158.

[23]KHAKH B S,GOLDMAN S A. Astrocytic contributions to Huntington’s disease pathophysiology[J]. Ann N Y Acad Sci,2023,1522(1):42-59.

[24]CALMA A D,PAVEY N,MENON P,et al. Neuroinflammation in amyotrophic lateral sclerosis:pathogenic insights and therapeutic implications[J]. Curr Opin Neurol,2024,37(5):585-592.

[25]石丽君，徐安琪，朱笠.神经退行性疾病中的TDP-43蛋白聚集和相变[J].生物化学与生物物理进展，2022,49(1):8-22.

[26]桂建军，孙晓东，温舒，等.白藜芦醇对帕金森病模型小鼠多巴胺能神经元的保护作用：基于抑制TLR4/MyD88/NF-κB通路[J].南方医科大学学报，2024,44(2):270-279.

[27]XIE Y L,LI X X,SHI Q Q,et al. The synergistic effect of curcumin and mitoquinol mesylate on cognitive impairment and the neuropathology of Alzheimer’s disease[J]. Brain Res,2024,1837:148959.

[28]WANG W S,WANG Y,WANG F J,et al. Gastrodin regulates the TLR4/TRAF6/NF-κB pathway to reduce neuroinflammation and microglial activation in an AD model[J]. Phytomedicine,2024,128:155518.

[29]LASURE V U ,SINGH GAUTAM A ,SINGH R K.Quercetin ameliorates neuroinflammatory and neurodegenerative biomarkers in the brain and improves neurobehavioral parameters in a repeated intranasal amyloid-beta exposed model of Alzheimer’s disease[J]. Food Funct,2024,15(17):8712-8728.

[30]LI B J,WANG M M,CHEN S,et al. Baicalin mitigates the neuroinflammation through the TLR4/MyD88/NF-κB and MAPK pathways in LPS-stimulated BV-2microglia[J]. Biomed Res Int,2022,2022:3263446.

[31]SUN X Y,LI L J,DONG Q X,et al. Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease[J]. J Neuroinflammation,2021,18(1):131.

[32]SOUZA L C,ANDRADE M K,AZEVEDO E M,et al.Andrographolide attenuates short-term spatial and recognition memory impairment and neuroinflammation induced by a streptozotocin rat model of Alzheimer’s disease[J]. Neurotox Res,2022,40(5):1440-1454.

[33]ŞAHIN S，ŞAHIN E,ESENÜLKÜG,et al. Oleuropein has modulatory effects on systemic lipopolysaccharideinduced neuroinflammation in male rats[J]. J Nutr,2024,154(4):1282-1297.

[34]张艺森，张玉，张新.基于Nrf2/NF-κB信号通路研究连翘苷对缺氧缺血性脑病新生大鼠神经元凋亡的影响[J].中草药，2025,56(10):3577-3584.

[35]WANG C Y,CHEN S S,GUO H Y,et al. Forsythoside a mitigates Alzheimer’s-like pathology by inhibiting ferroptosis-mediated neuroinflammation via Nrf2/GPX4 axis activation[J]. Int J Biol Sci,2022,18(5):2075-2090.

[36]LU S J,JI N,WANG W,et al. Salidroside improves cognitive function in Parkinson’s disease via Brafmediated mitogen-activated protein kinase signaling pathway[J]. Biomed Pharmacother,2024,177:116968.

[37]YANG L X,HUANG H H,FAN Y,et al. Astragaloside IV ameliorates Parkinson’s disease by inhibiting TLR4/NF-κB-dependent neuroinflammation[J]. Int Immunopharmacol,2025,160:114972.

[38]KONG L L,LIU Y,LI J W,et al. Ginsenoside Rg1 alleviates chronic inflammation-induced neuronal ferroptosis and cognitive impairments via regulation of AIM2-Nrf2 signaling pathway[J]. J Ethnopharmacol,2024,330:118205.

[39]CHIU Y J,LIN C H,LEE M C,et al. Formulated Chinese medicine Shaoyao Gancao Tang reduces NLRP1and NLRP3 in Alzheimer’s disease cell and mouse models for neuroprotection and cognitive improvement[J]. Aging,2021,13(11):15620-15637.

[40]LI Q Q,JIA C X,WU H X,et al. Nao Tan Qing ameliorates Alzheimer’s disease-like pathology by regulating glycolipid metabolism and neuroinflammation:a network pharmacology analysis and biological validation[J].Pharmacol Res,2022,185:106489.

[41]ZHOU L,YANG C Q,LIU Z Q,et al. Neuroprotective effect of the traditional decoction Tian-Si-Yin against Alzheimer’s disease via suppression of neuroinflammation[J]. J Ethnopharmacol,2024,321:117569.

[42]李世强，万继峰，果海姣，等.补肝汤联合多巴丝肼片治疗帕金森病的临床效果[J].中国医药导报，2024,21(2):90-94.

[43]林佳成，郑煊璐，王呈蕙，等.基于网络药理学原理探讨健脾补肾方治疗肌萎缩侧索硬化症的机制[J].上海中医药大学学报，2022,36(S1):180-186.

[44]许民栋，韩为，易玮，等.电针对阿尔茨海默病小鼠认知功能和肠道菌群的影响[J].针灸临床杂志，2025,41(1):71-77.

[45]KIM J H,CHOI Y,KIM J S,et al. Stimulation of microneedles alleviates pathology of Parkinson’s disease in mice by regulating the CD4+/CD8+cells from the periphery to the brain[J]. Front Immunol,2024,15:1454102.

[46]ZHAO Y D,ZHANG Z C,QIN S R,et al. Acupuncture for Parkinson’s disease:efficacy evaluation and mechanisms in the dopaminergic neural circuit[J].Neural Plast,2021,2021:9926445.

[47]LIU J Y,LU Y R,GUO J,et al. Effect of electroacupuncture intervention on the spinal cord PPIA/NF-κB signaling pathway in mice with amyotrophic lateral sclerosis[J]. Acupunct Res,2023,48(10):1009-1016.

[48]WU Z G,HUANG Y J,WANG T Y,et al. Effect of acupuncture on neuroinflammation in animal models of Alzheimer’s disease:a preclinical systematic review and meta-analysis[J]. Front Aging Neurosci,2023,15:1110087.

[49]蔡芳芳，丁勇，范德兰，等.针刺联合康复操治疗肌萎缩侧索硬化症患者的疗效观察[J].世界中西医结合杂志，2023,18(1):137-141.

[50]JEON H,OH J Y,AHN S,et al. Invasive laser acupuncture targeting muscle:a novel approach to protect dopaminergic neurons and reduce neuroinflammation in a brain of Parkinson’s disease model[J]. Chin Med,2025,20(1):59.